Tag: ANDA
Hatch-Waxman Act: How It Shaped Generic Drug Access in the U.S.
The Hatch-Waxman Act created the modern system for generic drug approval in the U.S., balancing innovation incentives with affordable access. It slashed drug costs by 90% for most prescriptions-but loopholes now threaten its success.
view morerecent posts
Most workplace wellness programs fail because employees don’t understand how they benefit. Learn how to educate staff with clear, personalized messaging that boosts participation, cuts costs, and builds trust.
Published ON: 1 FebLearn how post-marketing studies track drug safety after approval, using FAERS, Sentinel, and real-world data to catch hidden risks. Understand the systems, challenges, and future of pharmacovigilance.
Published ON: 11 FebDiscover how the FDA maintains strict quality standards for generic drugs through cGMP regulations, unannounced inspections, and rigorous testing. Learn about the five key control areas, global comparisons, and real-world impact on drug safety and affordability.
Published ON: 4 FebTeam-based care transforms how generic drugs are prescribed by bringing together doctors, pharmacists, and nurses to improve safety, adherence, and cost savings - especially for patients with multiple chronic conditions.
Published ON: 18 FebEdema in CKD is caused by fluid buildup from failing kidneys. Managing it requires a three-part strategy: the right diuretics, strict salt restriction, and compression therapy. Learn how each works-and how to use them safely.
Published ON: 7 Feb